Cargando…
Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress
Oral squamous cell carcinoma (OSCC), with aggressive locoregional invasion, has a high rate of early recurrences and poor prognosis. Dihydroartemisinin (DHA), as a derivative of artemisinin, has been found to exert potent antitumor activity. Recent studies reported that DHA suppresses OSCC cell grow...
Autores principales: | Shi, Shanwei, Luo, Huigen, Ji, Yuna, Ouyang, Huiya, Wang, Zheng, Wang, Xinchen, Hu, Renjie, Wang, Lihong, Wang, Yun, Xia, Juan, Cheng, Bin, Bao, Baicheng, Li, Xin, Liao, Guiqing, Xu, Baoshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239307/ https://www.ncbi.nlm.nih.gov/pubmed/37273554 http://dx.doi.org/10.1155/2023/9595201 |
Ejemplares similares
-
Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021) -
Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015) -
Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020) -
Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020) -
Combating Intracellular Pathogens with Repurposed
Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)